|
Volumn 26, Issue 3 SUPPL., 1997, Pages
|
National Institutes of Health Consensus Development Conference panel statement: Management of hepatitis C
a
a
NIHCDCP
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALBUMIN;
ALCOHOL;
ALPHA FETOPROTEIN;
ALPHA INTERFERON;
ALPHA2A INTERFERON;
ALPHAN1 INTERFERON;
ALPHAN3 INTERFERON;
BETA INTERFERON;
BILIRUBIN;
DNA;
HEPATITIS C ANTIBODY;
ILLICIT DRUG;
INTERFERON;
LIVER ENZYME;
NUCLEOTIDE;
RIBAVIRIN;
VACCINE;
VIRUS ANTIGEN;
VIRUS RNA;
BONE MARROW SUPPRESSION;
CHRONIC HEPATITIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE SEVERITY;
DISEASE TRANSMISSION;
ENZYME IMMUNOASSAY;
FATIGUE;
FLU LIKE SYNDROME;
HEMOLYTIC ANEMIA;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
IMMUNOBLOTTING;
LIVER BIOPSY;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
ORAL DRUG ADMINISTRATION;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
SEXUAL BEHAVIOR;
SUBCUTANEOUS DRUG ADMINISTRATION;
FORECASTING;
HEPATITIS C;
HUMANS;
PREVENTIVE MEDICINE;
RESEARCH;
UNITED STATES;
|
EID: 0030886964
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (667)
|
References (0)
|